144 related articles for article (PubMed ID: 37728155)
1. E2F1-EP300 co-activator complex potentiates immune escape in nasopharyngeal carcinoma through the mediation of MELK.
Wang Q; Yu Q; Liu Y
Histol Histopathol; 2024 Apr; 39(4):511-523. PubMed ID: 37728155
[TBL] [Abstract][Full Text] [Related]
2. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXA10-AS Activated by E2F1 Facilitates Proliferation and Migration of Nasopharyngeal Carcinoma Cells Through Sponging miR-582-3p to Upregulate RAB31.
Wang X; Nie P; Zhu D
Am J Rhinol Allergy; 2022 May; 36(3):348-359. PubMed ID: 35072529
[TBL] [Abstract][Full Text] [Related]
4. A significant role of transcription factors E2F in inflammation and tumorigenesis of nasopharyngeal carcinoma.
Liu P; Zhang X; Li Z; Wei L; Peng Q; Liu C; Wu Y; Yan Q; Ma J
Biochem Biophys Res Commun; 2020 Apr; 524(4):816-824. PubMed ID: 32044038
[TBL] [Abstract][Full Text] [Related]
5. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
6. CDC25A inhibition suppresses cell proliferation and induces G
Wang B; Gong Q; Chen F
Mol Med Rep; 2023 May; 27(5):. PubMed ID: 37052240
[TBL] [Abstract][Full Text] [Related]
7. MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.
Wang LQ; Deng AC; Zhao L; Li Q; Wang M; Zhang Y
J Biol Regul Homeost Agents; 2019; 33(2):321-330. PubMed ID: 30972994
[TBL] [Abstract][Full Text] [Related]
8. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
9. LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis.
Xie T; Du K; Liu W; Liu C; Wang B; Tian Y; Li R; Huang X; Lin J; Jian H; Zhang J; Yuan Y
Br J Cancer; 2022 Oct; 127(7):1239-1253. PubMed ID: 35864158
[TBL] [Abstract][Full Text] [Related]
10. E2F3 renders an immunosuppressive tumor microenvironment in nasopharyngeal carcinoma: Involvements of the transcription activation of PRC1 and BIRC5.
Wang Q; Yu Q; Liu Y
Immun Inflamm Dis; 2023 Aug; 11(8):e987. PubMed ID: 37647439
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
[TBL] [Abstract][Full Text] [Related]
12. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
Cui Z; Zhao Y
BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
[TBL] [Abstract][Full Text] [Related]
13. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
[TBL] [Abstract][Full Text] [Related]
14. ANKRD22 promotes glioma proliferation, migration, invasion, and epithelial-mesenchymal transition by upregulating E2F1-mediated MELK expression.
Liu X; Zhao J; Wu Q; Wang L; Lu W; Feng Y
J Neuropathol Exp Neurol; 2023 Jun; 82(7):631-640. PubMed ID: 37164633
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA long intergenic non-protein-coding RNA 173 contributes to nasopharyngeal carcinoma progression by regulating microRNA-765/Gremlin 1 pathway.
Wang D; Jiang H
Hum Exp Toxicol; 2023; 42():9603271231172921. PubMed ID: 37365917
[TBL] [Abstract][Full Text] [Related]
16. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA ANCR promotes migration, invasion, EMT progress and stemness of nasopharyngeal carcinoma cells via the miR-4731-5p/NMT1 axis.
Ma X; Yuan Y; Lu J; Li M; Yu Y; Liu J; Zhou J
Pathol Res Pract; 2021 Aug; 224():153540. PubMed ID: 34333213
[TBL] [Abstract][Full Text] [Related]
18. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
19. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
Zhang Y; Zhang W
Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
[TBL] [Abstract][Full Text] [Related]
20. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
